Span Divergent Ltd
₹ 21.8
-4.97%
23 May
- close price
About
Incorporated in 1972, Span Divergent Ltd invests in Cashew Processing, Plant Tissue Culture and Trading of consumables used in Pharma/Biotech Industries.
Key Points
- Market Cap ₹ 11.9 Cr.
- Current Price ₹ 21.8
- High / Low ₹ 45.3 / 18.2
- Stock P/E 15.1
- Book Value ₹ 63.6
- Dividend Yield 0.00 %
- ROCE 2.51 %
- ROE 2.29 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.34 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -1.20% over past five years.
- Company has a low return on equity of 1.82% over last 3 years.
- Contingent liabilities of Rs.4.03 Cr.
- Earnings include an other income of Rs.1.21 Cr.
- Debtor days have increased from 47.0 to 74.8 days.
- Working capital days have increased from 219 days to 991 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Miscellaneous Industry: Miscellaneous
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78.37 | 72.71 | 0.00 | 2.39 | 1.70 | 1.73 | 1.71 | 1.46 | 1.96 | 1.96 | 1.91 | 1.61 | |
| 74.43 | 71.21 | 5.08 | 6.58 | 5.99 | 2.97 | 2.02 | 1.39 | 1.50 | 1.46 | 1.68 | 1.59 | |
| Operating Profit | 3.94 | 1.50 | -5.08 | -4.19 | -4.29 | -1.24 | -0.31 | 0.07 | 0.46 | 0.50 | 0.23 | 0.02 |
| OPM % | 5.03% | 2.06% | -175.31% | -252.35% | -71.68% | -18.13% | 4.79% | 23.47% | 25.51% | 12.04% | 1.24% | |
| 1.01 | 49.37 | 9.99 | 4.02 | 2.77 | -0.60 | 0.96 | 0.64 | -8.03 | -3.37 | 1.63 | 1.21 | |
| Interest | 4.41 | 4.36 | 0.00 | 0.17 | 0.70 | 0.17 | 0.23 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 4.77 | 5.83 | 0.17 | 0.34 | 0.56 | 1.12 | 0.92 | 0.65 | 0.51 | 0.42 | 0.34 | 0.25 |
| Profit before tax | -4.23 | 40.68 | 4.74 | -0.68 | -2.78 | -3.13 | -0.50 | 0.02 | -8.08 | -3.29 | 1.52 | 0.98 |
| Tax % | 21.51% | 13.59% | 25.74% | 23.53% | 10.79% | 3.51% | -28.00% | 100.00% | -3.96% | 1.22% | 0.00% | 14.29% |
| -5.14 | 35.15 | 3.53 | -0.84 | -3.08 | -3.24 | -0.35 | 0.00 | -7.76 | -3.34 | 1.51 | 0.84 | |
| EPS in Rs | -7.06 | 48.31 | 6.46 | -1.54 | -5.64 | -5.93 | -0.64 | 0.00 | -14.21 | -6.12 | 2.76 | 1.54 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -32% |
| 5 Years: | -1% |
| 3 Years: | -6% |
| TTM: | -16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 26% |
| 3 Years: | -4% |
| TTM: | 80% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | 18% |
| 3 Years: | 11% |
| 1 Year: | -5% |
| Return on Equity | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 1% |
| 3 Years: | 2% |
| Last Year: | 2% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.28 | 7.28 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 |
| Reserves | 16.46 | 51.51 | 45.07 | 45.03 | 41.95 | 38.63 | 38.26 | 38.27 | 30.51 | 27.16 | 28.66 | 29.29 |
| 37.44 | 0.00 | 0.00 | 8.50 | 9.82 | 4.19 | 2.89 | 3.14 | 2.86 | 2.75 | 2.08 | 2.23 | |
| 29.00 | 3.54 | 0.46 | 1.01 | 1.62 | 1.32 | 2.80 | 2.97 | 1.96 | 2.18 | 2.16 | 2.98 | |
| Total Liabilities | 90.18 | 62.33 | 50.99 | 60.00 | 58.85 | 49.60 | 49.41 | 49.84 | 40.79 | 37.55 | 38.36 | 39.96 |
| 42.56 | 0.40 | 2.12 | 5.89 | 9.28 | 8.17 | 5.52 | 4.87 | 4.28 | 3.86 | 3.31 | 3.38 | |
| CWIP | 4.41 | 0.00 | 0.03 | 0.92 | 0.00 | 0.01 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.64 | 46.36 | 38.39 | 44.78 | 47.02 | 39.79 | 40.02 | 42.88 | 35.10 | 31.86 | 33.22 | 35.15 |
| 42.57 | 15.57 | 10.45 | 8.41 | 2.55 | 1.63 | 3.85 | 2.07 | 1.41 | 1.83 | 1.83 | 1.43 | |
| Total Assets | 90.18 | 62.33 | 50.99 | 60.00 | 58.85 | 49.60 | 49.41 | 49.84 | 40.79 | 37.55 | 38.36 | 39.96 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.99 | 44.99 | -4.14 | -0.93 | 2.44 | -1.09 | 1.10 | 0.37 | -0.31 | 0.58 | 0.53 | 1.00 | |
| -5.60 | -5.83 | 10.26 | -8.56 | -2.52 | 6.39 | 0.47 | -0.57 | 0.43 | -0.36 | 0.16 | -1.10 | |
| -3.92 | -32.35 | -12.16 | 8.33 | 0.67 | -5.82 | -1.97 | 0.30 | -0.20 | -0.02 | -0.56 | 0.15 | |
| Net Cash Flow | -0.53 | 6.81 | -6.04 | -1.16 | 0.59 | -0.52 | -0.41 | 0.10 | -0.08 | 0.20 | 0.13 | 0.04 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 81.60 | 0.00 | 0.00 | 62.26 | 50.64 | 49.09 | 30.00 | 18.62 | 29.80 | 36.31 | 74.81 | |
| Inventory Days | 190.61 | 0.00 | 0.00 | |||||||||
| Days Payable | 117.23 | |||||||||||
| Cash Conversion Cycle | 154.98 | 0.00 | 0.00 | 62.26 | 50.64 | 49.09 | 30.00 | 18.62 | 29.80 | 36.31 | 74.81 | |
| Working Capital Days | 18.54 | -10.44 | 140.50 | 137.41 | 116.04 | 266.81 | -185.00 | -119.18 | -178.78 | -154.79 | 990.71 | |
| ROCE % | 0.28% | -3.68% | -5.58% | -5.97% | -6.11% | -2.54% | -1.33% | 0.02% | 1.31% | 1.73% | 1.26% | 2.51% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
17 May - Span Divergent Limited - Newspaper Advertisement
- Span Divergent Limited - Intimation Of Book Closure 16 May
-
Announcement Under Regulation 30 Of SEBI LODR - Re-Appointment Of Internal Auditor
16 May - Re-appointment of M/s. Christie & Co. as internal auditor for FY 2025-26.
-
Announcement Under Regulation 30 Of SEBI LODR- Re-Appointment Of Secretarial Auditor
16 May - Re-appointment of M/s. Mitesh Rana & Co. as secretarial auditor for five years from 2025-26 to 2029-30.
-
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
16 May - Re-appointment of M/s. Y. B. Desai & Associates as statutory auditor for 2025-26 to 2029-30.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Services Offered:[1]
Company is operating in various businesses through specific subsidiary firm formed for each of the businesses.
a) Dryfruit Factory LLP (DFFL):
Company has a plant near Ahmedabad for processing of Raw Cashew Nuts (RCNs) into a finished cashew. Its commercial production
started in Q2FY18
b) Aranya Agri Biotech LLP (AABL):
It is involved in Plant Tissue Culture business which falls into Agriculture Activities. It is also doing Research and Development to make new products which can be cultivated through tissue culture techniques
c) Desai Farmharvest LLP:
No operation has started in this LLP
d) Biospan Scientific LLP (BSLLP):
This focuses on areas of Microbiology, Protein research and Scientific Laboratory products. As of now, LLP has limited products under its name.
e) Biospan Contamination Control Solutions Private Limited (BSCCS):
BSCCS is a joint venture formed between Span Divergent Ltd. and Micronclean UK, with Span having 67% equity stake. It caters to Pharma along with Biotechnology industry having clean room consumable requirement. Products are imported from Joint Venture Partner Company from UK and other reputed companies world-wide operating in similar segment.
f) Span Diagnostics LLP:
No operation has started in this LLP
g) Span Diagnostics South Africa (PTY) Limited:
Being an inoperative entity, company has initiated process either to divest its investment from this venture or close down the same.